Skip to main content

Keenova Therapeutics plc

MNKTQDelisted Sep 6, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001567892

Keenova Therapeutics plc was delisted on Sep 6, 2023; its insiders filed their last Form 4 on Oct 6, 2026; 36 institutions reported holding it in 13F filings for Q2 2023, worth $12.4M in total; no superinvestor held it.

Q4 2021 vs. Q3 2021

How the institutions holding Keenova Therapeutics plc changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of MNKTQ: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders1012+2
Shares5.52K2.32K−3.19K (−57.9%)
Value$4.15K$8.09K+$3.94K (+95.0%)

New holders (3)

Institutions that held Keenova Therapeutics plc at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to MNKTQ in Q4 2021
InstitutionSharesValue% of portfolio
Sofos Investments, Inc.0$6.00K0.00%
Cassady Schiller Wealth Management, LLC4$00.00%
Financial Connections Group, Inc.1$00.00%

Sold out (1)

Institutions that held Keenova Therapeutics plc at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of MNKTQ in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Meeder Asset Management Inc3,131$1.00K